Drug firm Sanofi India on Wednesday said its net profit declined by 6.38 per cent to Rs 51.3 crore for the quarter ended September 30, 2012, mainly due to increase in the cost of materials and amortisation costs as against a net profit of Rs 54.8 crore for the same quarter last fiscal.
Total income from operations of the company however rose to Rs 416 crore ( Rs 332.5 cr) Sanofi India said in a BSE filing.
The profit for the quarter and nine months ended September 30, 2012 had been impacted due the amortisation costs relating to brands, technical know—how and goodwill acquired from Universal Medical and lower interest income as a result of the that, Sanofi India said.
Shares of Sanofi India closed at Rs 2,247.95 apiece on the BSE, up 2.39 per cent from their previous close.